Literature DB >> 32239761

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.

Qingxian Cai1, Deliang Huang1, Pengcheng Ou2, Hong Yu1, Zhibin Zhu1, Zhang Xia1, Yinan Su3, Zhenghua Ma1, Yiming Zhang1, Zhiwei Li1, Qing He1, Lei Liu1, Yang Fu3, Jun Chen1.   

Abstract

BACKGROUND: The clinical characteristics of novel coronavirus disease (COVID-2019) patients outside the epicenter of Hubei Province are less understood.
METHODS: We analyzed the epidemiological and clinical features of all COVID-2019 cases in the only referral hospital in Shenzhen City, China, from January 11, 2020, to February 6, 2020, and followed until March 6, 2020.
RESULTS: Among the 298 confirmed cases, 233 (81.5%) had been to Hubei, while 42 (14%) did not have a clear travel history. Only 218 (73.15%) cases had a fever as the initial symptom. Compared with the nonsevere cases, severe cases were associated with older age, those with underlying diseases, and higher levels of C-reactive protein, interleukin-6, and erythrocyte sedimentation rate. Slower clearance of the virus was associated with a higher risk of progression to critical condition. As of March 6, 2020, 268 (89.9%) patients were discharged and the overall case fatality ratio was 1.0%.
CONCLUSIONS: In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  corona Virus Disease 2019; epidemiological features; severe acute respiratory syndrome coronavirus 2; severe pneumonia

Year:  2020        PMID: 32239761     DOI: 10.1111/all.14309

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  177 in total

1.  Response to the COVID-19 epidemic: a report from Shenzhen, China.

Authors:  Xin Zhao; Youchun Wu; Zhiwei Li; Lei Liu
Journal:  Glob Health Med       Date:  2020-04-30

Review 2.  Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Authors:  Henok Kessete Afewerky
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-07

3.  The Comparison of Sarcopenia Diagnostic Criteria using AWGS 2019 with the Other Five Criteria in West China.

Authors:  Xiaolei Liu; Lisha Hou; Wanyu Zhao; Xin Xia; Fengjuan Hu; Gongchang Zhang; Qiukui Hao; Lixing Zhou; Yixin Liu; Meiling Ge; Yan Zhang; Jirong Yue; Birong Dong
Journal:  Gerontology       Date:  2021-02-17       Impact factor: 5.140

4.  Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19.

Authors:  Kamleshun Ramphul; Petras Lohana; Yogeshwaree Ramphul; Yun Park; Stephanie Mejias; Balkiranjit Kaur Dhillon; Shaheen Sombans; Renuka Verma
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-04-12

5.  Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.

Authors:  Yunlong Ma; Yukuan Huang; Sen Zhao; Yinghao Yao; Yaru Zhang; Jia Qu; Nan Wu; Jianzhong Su
Journal:  Hum Mol Genet       Date:  2021-06-17       Impact factor: 6.150

6.  Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients.

Authors:  Alberto Polimeni; Isabella Leo; Carmen Spaccarotella; Annalisa Mongiardo; Sabato Sorrentino; Jolanda Sabatino; Salvatore De Rosa; Ciro Indolfi
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 7.  COVID-19 impact on the liver.

Authors:  Liliana Baroiu; Caterina Dumitru; Alina Iancu; Ana-Cristina Leșe; Miruna Drăgănescu; Nicușor Baroiu; Lucreția Anghel
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

8.  Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections.

Authors:  Christine J Kubin; Thomas H McConville; Donald Dietz; Jason Zucker; Michael May; Brian Nelson; Elizabeth Istorico; Logan Bartram; Jennifer Small-Saunders; Magdalena E Sobieszczyk; Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  Open Forum Infect Dis       Date:  2021-05-05       Impact factor: 3.835

Review 9.  Prevalence of Comorbidities in COVID-19 Patients: A Systematic Review and Meta-Analysis.

Authors:  Ashkan Baradaran; Mohammad H Ebrahimzadeh; Aslan Baradaran; Amir R Kachooei
Journal:  Arch Bone Jt Surg       Date:  2020-04

Review 10.  Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know?

Authors:  Anna Licata; Maria Giovanna Minissale; Marco Distefano; Giuseppe Montalto
Journal:  GastroHep       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.